Group One Trading’s Aethlon Medical AEMD Stock Holding History

Group One Trading’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12	Hold	3	–	–	﹤0.01%	7447
2026 Q1	$31	Hold	3	–	–	﹤0.01%	7457
2025 Q4	$39	Hold	3	–	–	﹤0.01%	7944
2025 Q3	$113	Hold	3	–	–	﹤0.01%	8238
2025 Q2	$181	Hold	3	–	–	﹤0.01%	7749
2025 Q1	$436	Hold	3	–	–	﹤0.01%	7297
2024 Q4	$1.05K	Hold	3	–	–	﹤0.01%	6878
2024 Q3	$568	Hold	3	–	–	﹤0.01%	6383
2024 Q2	$607	Hold	3	–	–	﹤0.01%	6433
2024 Q1	$2.04K	Hold	3	–	–	﹤0.01%	6485
2023 Q4	$2.89K	Sell	3 -1	-25%	-$711	﹤0.01%	6710
2023 Q3	$3.51K	Hold	4	–	–	﹤0.01%	6851
2023 Q2	$5.68K	Hold	4	–	–	﹤0.01%	6670
2023 Q1	$6.88K	Sell	4 -3	-43%	-$5.65K	﹤0.01%	6145
2022 Q4	$7.4K	Sell	7 -1	-13%	-$1.82K	﹤0.01%	6158
2022 Q3	$19K	Buy	8 +6	+300%	+$26K	﹤0.01%	6091
2022 Q2	$7K	Sell	2 -3	-60%	-$14K	﹤0.01%	6918
2022 Q1	$29K	Buy	+5	New	+$29.8K	﹤0.01%	6494

Other funds holding AEMD

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Group One Trading's AEMD Position: Q2 2026 in Review

Group One Trading held its Aethlon Medical (AEMD) position steady in Q2 2026 at 3 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #7447.

Group One Trading first reported a position in AEMD in Q1 2022 and has held it in 18 quarters since. The position peaked at $29K in Q1 2022. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

Group One Trading held 3 shares of Aethlon Medical worth $12 as of Q2 2026.
Group One Trading left its Aethlon Medical share count unchanged in Q2 2026.
Aethlon Medical made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7447 holding.
Group One Trading first reported a position in Aethlon Medical in Q1 2022 and has held it in 18 quarters since.
Group One Trading's Aethlon Medical position peaked at $29K in Q1 2022.
15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.